Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950103-24-013849
Filing Date
2024-09-23
Accepted
2024-09-23 16:39:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dp218057_defa14a.htm DEFA14A 23468
2 GRAPHIC image_001.jpg GRAPHIC 450376
3 GRAPHIC image_002.jpg GRAPHIC 321141
  Complete submission text file 0000950103-24-013849.txt   1087404
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39071 | Film No.: 241316644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)